Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleonora Da Pozzo

Showing results (71-80 of 95) with videos related to

Pageof 10
Sort By:
Journal of Medicinal Chemistry|April 7, 2016
Lead Optimization of 2-Phenylindolylglyoxylyldipeptide Murine Double Minute (MDM)2/Translocator Protein (TSPO) Dual Inhibitors for the Treatment of GliomasSimona Daniele, Valeria La Pietra, Elisabetta Barresi, et al.
Journal of Medicinal Chemistry|March 4, 2014
Structure-activity relationship refinement and further assessment of 4-phenylquinazoline-2-carboxamide translocator protein ligands as antiproliferative agents in human glioblastoma tumorsSabrina Castellano, Sabrina Taliani, Monica Viviano, et al.
Journal of Medicinal Chemistry|April 12, 2012
Synthesis and biological evaluation of 4-phenylquinazoline-2-carboxamides designed as a novel class of potent ligands of the translocator proteinSabrina Castellano, Sabrina Taliani, Ciro Milite, et al.
Journal of Medicinal Chemistry|May 5, 2010
Novel irreversible fluorescent probes targeting the 18 kDa translocator protein: synthesis and biological characterizationSabrina Taliani, Eleonora Da Pozzo, Marusca Bellandi, et al.
Cellular and Molecular Life Sciences : CMLS|January 5, 2025
18 kDa TSPO targeting drives polarized human microglia towards a protective and restorative neurosteroidome profileLorenzo Germelli, Elisa Angeloni, Eleonora Da Pozzo, et al.
Plos One|August 27, 2013
Human glioblastoma multiforme: p53 reactivation by a novel MDM2 inhibitorBarbara Costa, Sara Bendinelli, Pamela Gabelloni, et al.
European Journal of Medicinal Chemistry|April 26, 2011
Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitorsElisa Nuti, Francesca Casalini, Salvatore Santamaria, et al.
Journal of Medicinal Chemistry|August 30, 2008
Anxiolytic-like effects of N,N-dialkyl-2-phenylindol-3-ylglyoxylamides by modulation of translocator protein promoting neurosteroid biosynthesisFederico Da Settimo, Francesca Simorini, Sabrina Taliani, et al.
Molecular Neurobiology|May 21, 2026
Mild Cognitive Impairment Associated with Obstructive Sleep Apnoea: A Pilot Study on Oxygen-Related Plasma Biomarkers and Network AnalysisMartina De Felice, Alessia Pascazio, Rebecca Piccarducci, et al.
Scientific Reports|April 24, 2014
Apoptosis therapy in cancer: the first single-molecule co-activating p53 and the translocator protein in glioblastomaSimona Daniele, Sabrina Taliani, Eleonora Da Pozzo, et al.
Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Journal of Medicinal Chemistry|April 7, 2016
Lead Optimization of 2-Phenylindolylglyoxylyldipeptide Murine Double Minute (MDM)2/Translocator Protein (TSPO) Dual Inhibitors for the Treatment of GliomasSimona Daniele, Valeria La Pietra, Elisabetta Barresi, et al.
Journal of Medicinal Chemistry|March 4, 2014
Structure-activity relationship refinement and further assessment of 4-phenylquinazoline-2-carboxamide translocator protein ligands as antiproliferative agents in human glioblastoma tumorsSabrina Castellano, Sabrina Taliani, Monica Viviano, et al.
Journal of Medicinal Chemistry|April 12, 2012
Synthesis and biological evaluation of 4-phenylquinazoline-2-carboxamides designed as a novel class of potent ligands of the translocator proteinSabrina Castellano, Sabrina Taliani, Ciro Milite, et al.
Journal of Medicinal Chemistry|May 5, 2010
Novel irreversible fluorescent probes targeting the 18 kDa translocator protein: synthesis and biological characterizationSabrina Taliani, Eleonora Da Pozzo, Marusca Bellandi, et al.
Cellular and Molecular Life Sciences : CMLS|January 5, 2025
18 kDa TSPO targeting drives polarized human microglia towards a protective and restorative neurosteroidome profileLorenzo Germelli, Elisa Angeloni, Eleonora Da Pozzo, et al.
Plos One|August 27, 2013
Human glioblastoma multiforme: p53 reactivation by a novel MDM2 inhibitorBarbara Costa, Sara Bendinelli, Pamela Gabelloni, et al.
European Journal of Medicinal Chemistry|April 26, 2011
Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitorsElisa Nuti, Francesca Casalini, Salvatore Santamaria, et al.
Journal of Medicinal Chemistry|August 30, 2008
Anxiolytic-like effects of N,N-dialkyl-2-phenylindol-3-ylglyoxylamides by modulation of translocator protein promoting neurosteroid biosynthesisFederico Da Settimo, Francesca Simorini, Sabrina Taliani, et al.
Molecular Neurobiology|May 21, 2026
Mild Cognitive Impairment Associated with Obstructive Sleep Apnoea: A Pilot Study on Oxygen-Related Plasma Biomarkers and Network AnalysisMartina De Felice, Alessia Pascazio, Rebecca Piccarducci, et al.
Scientific Reports|April 24, 2014
Apoptosis therapy in cancer: the first single-molecule co-activating p53 and the translocator protein in glioblastomaSimona Daniele, Sabrina Taliani, Eleonora Da Pozzo, et al.
Pageof 10